BPA - Laboratory Supplies/Reagents - Crownpoint Healthcare Facility

Where this opportunity stands

Every notice posted under solicitation 75H71026Q00179 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Answer the notice: this is when the requirement can still be shaped.
• Contact the contracting officer named on the notice.
• Check who won similar work; they are the likely bidders.

Who won similar work

4 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Indian Health Service), same product/service code (PSC) 6550.

Single-winner award sizes (4): middle half $65K to $114K, median $80K; range $22K to $215K.

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

• Sep 11, 2026GOVERNMENT SCIENTIFIC SOURCE INC$215KLaboratory Quality Control Materials - Zuni Comprehensive Community Health Center (ZCCHC)No listed company matched (Materiality N/A)
• May 28, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$80KBrand Name or Equal Ortho Diagnostics Blood Bank and Quality Control Supplies, IHS, Hopi Health Care Center, 5-Year BPAMateriality: <0.01% of $QDEL revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $80K award ÷ $2.7B revenue, 12 months to Jun 28, 2026 (SEC 10-Q). SEC
• May 19, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$80KBrand Name or Equal Ortho Diagnostics Blood Bank and Quality Control Supplies, IHS, Hopi Health Care Center, 5-Year BPAMateriality: <0.01% of $QDEL revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $80K award ÷ $2.7B revenue, 12 months to Jun 28, 2026 (SEC 10-Q). SEC
• Jan 8, 2025ABBOTT LABORATORIES INC.$22KLimited Sources Justification (LSJ): Firm Fixed-Price, Non-Personal Service Type, Commercial Item DO/TO to provide Immunoassay Reagents, Supplies, and Cost Per Reportable Result Analyzer Services for Materiality: <0.01% of $ABT revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $22K award ÷ $45.1B revenue, 12 months to Mar 31, 2026 (SEC 10-Q). SEC

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.